INT MEDICAL Reports Annual Profit Increase of 22.43% to 233 Million Yuan

Stock News03-27

INT MEDICAL (01501) announced its financial results for the year ended December 31, 2025. The company recorded revenue of 1.065 billion yuan, representing a year-on-year increase of 25.06%. Gross profit reached 637 million yuan, up 18.44% compared to the previous year. Net profit amounted to 233 million yuan, a growth of 22.43%. Earnings per share were 1.26 yuan. The board proposed a dividend of 0.23 yuan per share.

According to the announcement, the increase in revenue was driven by a rise in new customers and business consolidation. During the reporting period, revenue from the sales of interventional medical devices was approximately 968 million yuan, an increase of about 25.17% compared to approximately 773 million yuan in the year ended December 31, 2024.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment